Abstract:
본 발명은 간동맥 가이딩 카테타링이 가능한 블록공중합체로 이루어진 약물전달체와 상기 약물전달체 내부에 담지된 치료 약물을 포함하며, 상기 약물전달체가 외부에서는 졸상이고, 간동맥에서는 젤 상태로 전이되어 간동맥의 혈액공급을 지연 내지 차단하며, 간동맥에서 젤 상태로 전이되는과정에서 상기 치료 약물이 서서히 방출되는 온도 및 pH 민감성 하이드로젤의 인터벤셔널 인젝션에 기반한 간암치료용 약물전달체를 제공한다.
Abstract:
본 발명은 고분자를 이용한 췌장소도 봉입용 캡슐(encapsulated pancreatic islets) 표면의 개질 방법에 관한 것으로서, 구체적으로 췌장소도를 캡슐로 봉입(encapsulation)한 후 다양한 고분자 결합(polymeric grafting)을 이용하여 폴리에틸렌 글리콜(polyethylene glycol, PEG)과 같은 고분자 사슬을 췌장소도 캡슐의 표면에 결합시켜 표면을 개질하는 방법에 관한 것이다. 본 발명의 표면개질 방법에 의해 표면이 변형된 췌장소도는 이식시 면역거부 반응을 최소화할 뿐만 아니라, 섬유아세포에 의한 섬유화도 막을 수 있어 췌장소도의 효율과 생존기간을 연장시킬 수 있다.
Abstract:
PURPOSE: A secretion signal peptide-linked exendin-4 transduced pancreatic islet and a method for treating diabetes using the same are provided to improve insulin secretion ability and to reduce cell necrosis rate. CONSTITUTION: A pancreatic islet cell cluster is transduced with a vector with a gene construct containing genes encoding secretion signal peptide and a gene encoding exendin-4. The pancreatic islet cell cluster is prepared by culturing the pancreatic islet cell cluster for 3-9 days. The surface of the pancreatic islet cell cluster is modified with biocompatible polymers, PEG(polyethylene glycol). A composition for treating diabetes contains the pancreatic islet cell cluster as an active ingredient.
Abstract:
The present invention relates to a CT contrast agent for detecting blood clot containing a fibrin target peptide sequence conjugated glycol chitosan-gold nanoparticle. The a CT contrast agent for detecting blood clot enables users to rapidly and repeatedly obtain CT image information of the size and the location of the blood clot in cardio-cerebrovascular thrombosis, and to monitor images of cerebral thrombosis.
Abstract:
PURPOSE: A drug delivery system for treating liver cancer based on interventional injection of temperature- and pH-sensitive hydrogel is provided to stably support an anticancer agent and to enable deep injection into microvessel. CONSTITUTION: A drug delivery system for treating liver cancer based on interventional injection of temperature- and pH-sensitive hydrogel contains a drug delivery system with a block copolymer and a therapeutic drug supported inside the drug delivery system. The drug delivery system further contains a contrast agent inside. The block copolymer is a poly(beta-amino ester)-based block copolymer, a polyamidoamine-based polymer, a polyaminoester urethane-based block copolymer, or a sulfonamide-based block copolymer. The poly(beta-amino ester)-based block copolymer is poly(beta-amino ester)-polyethylene glycol-poly(beta-amino ester)(PAE-PEG-PAE), PAE-PCLA-PEG-PCLA-PAE, PAE-PCL-PEG-PCL-PAE or PAEPCGA-PEG-PCGA-PAE. [Reference numerals] (AA) Embodiment 14; (BB) Embodiment 15; (CC) Embodiment 16; (DD) Control group
Abstract:
PURPOSE: A capsule for encapsulating pancreas islet having modified surface and a preparation method thereof are provided to effectively block the attack of an immune cell. CONSTITUTION: A capsule for encapsulating pancreas islet having modified surface is as follows. Pancreas islet is encapsulated in a capsule comprised of alginate. The capsule surface is reformed by biocompatible polymer. In the biocompatible polymer, a functional radical is attached to the side chain or end thereof. The functional radical is selected from a group consisting of an amine radical, hydroxyl radical, a carboxyl radical, and a sulfone radical.